TABLE 2.
Methylation differences of S100P between BC cases and controls in Study I stratify by median of age.
| Age | CpG sites | Controls median (IQR) | BC cases median (IQR) | OR (95% CI)* per −10% methylation | p-value* |
| Age ≤ 45 (case = 144 Control = 192) | S100P_CpG_2.3 | 0.63 (0.59–0.66) | 0.64 (0.61–0.68) | 0.46 (0.24–0.86) | 0.016 |
| S100P_CpG_4 | 0.69 (0.66–0.74) | 0.71 (0.68–0.76) | 0.68 (0.42–1.12) | 0.130 | |
| S100P_CpG_7 | 0.40 (0.35–0.46) | 0.41 (0.34–0.48) | 0.81 (0.61–1.08) | 0.157 | |
| S100P_CpG_8 | 0.46 (0.41–0.51) | 0.48 (0.42–0.54) | 0.85 (0.60–1.19) | 0.343 | |
| S100P_CpG_9 | 0.49 (0.42–0.56) | 0.49 (0.44–0.55) | 0.61 (0.41–0.91) | 0.014 | |
| S100P_CpG_10.11.12 | 0.61 (0.57–0.64) | 0.64 (0.58–0.67) | 0.55 (0.35–0.88) | 0.012 | |
| Age > 45 (case = 143 Control = 140) | S100P_CpG_2.3 | 0.65 (0.62–0.69) | 0.67 (0.62–0.70) | 1.39 (0.58–3.34) | 0.458 |
| S100P_CpG_4 | 0.72 (0.68–0.76) | 0.71 (0.68–0.76) | 0.76 (0.40–1.46) | 0.407 | |
| S100P_CpG_7 | 0.43 (0.36–0.51) | 0.42 (0.35–0.46) | 1.33 (0.89–1.99) | 0.163 | |
| S100P_CpG_8 | 0.50 (0.44–0.54) | 0.51 (0.43–0.57) | 1.49 (0.93–2.39) | 0.102 | |
| S100P_CpG_9 | 0.55 (0.46–0.59) | 0.58 (0.48–0.64) | 0.77 (0.44–1.35) | 0.358 | |
| S100P_CpG_10.11.12 | 0.63 (0.60–0.67) | 0.64 (0.61–0.68) | 0.89 (0.48–1.66) | 0.717 |
*Logistic regression, adjusted for age and batches of measurement. BC, breast cancer; S100P, S100 calcium-binding protein P gene; OR, odds ratio; IQR, interquartile range. The bold values indicate p < 0.05.